GW&K Investment Management LLC lifted its stake in Balchem Co. (NASDAQ:BCPC) by 15.8% in the 3rd quarter, Holdings Channel.com reports. The firm owned 391,005 shares of the basic materials company’s stock after buying an additional 53,468 shares during the quarter. GW&K Investment Management LLC’s holdings in Balchem were worth $38,783,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Ladenburg Thalmann Financial Services Inc. increased its holdings in Balchem by 3.2% in the 2nd quarter. Ladenburg Thalmann Financial Services Inc. now owns 3,882 shares of the basic materials company’s stock worth $388,000 after buying an additional 119 shares in the last quarter. State of Alaska Department of Revenue increased its holdings in Balchem by 1.3% in the 2nd quarter. State of Alaska Department of Revenue now owns 11,007 shares of the basic materials company’s stock worth $1,100,000 after buying an additional 143 shares in the last quarter. Cambridge Investment Research Advisors Inc. increased its holdings in Balchem by 3.2% in the 2nd quarter. Cambridge Investment Research Advisors Inc. now owns 4,863 shares of the basic materials company’s stock worth $486,000 after buying an additional 149 shares in the last quarter. First Trust Advisors LP increased its holdings in Balchem by 3.2% in the 2nd quarter. First Trust Advisors LP now owns 5,088 shares of the basic materials company’s stock worth $509,000 after buying an additional 156 shares in the last quarter. Finally, Municipal Employees Retirement System of Michigan increased its holdings in Balchem by 1.7% in the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 9,650 shares of the basic materials company’s stock worth $965,000 after buying an additional 160 shares in the last quarter. 86.33% of the stock is owned by hedge funds and other institutional investors.

Shares of Balchem stock traded up $0.39 during trading hours on Friday, reaching $103.44. 101,700 shares of the stock traded hands, compared to its average volume of 114,443. The company has a 50 day moving average price of $99.87 and a 200 day moving average price of $96.93. The company has a quick ratio of 2.63, a current ratio of 3.33 and a debt-to-equity ratio of 0.32. Balchem Co. has a one year low of $73.16 and a one year high of $106.56. The firm has a market capitalization of $3.25 billion, a price-to-earnings ratio of 34.37 and a beta of 1.20.

Balchem (NASDAQ:BCPC) last posted its quarterly earnings results on Tuesday, November 5th. The basic materials company reported $0.81 EPS for the quarter, topping the Zacks’ consensus estimate of $0.74 by $0.07. Balchem had a return on equity of 14.01% and a net margin of 12.43%. The company had revenue of $158.60 million for the quarter, compared to analysts’ expectations of $166.42 million. During the same period in the previous year, the firm earned $0.73 EPS. The firm’s revenue was up 2.3% compared to the same quarter last year. Sell-side analysts anticipate that Balchem Co. will post 3.06 earnings per share for the current year.

In related news, VP David F. Ludwig sold 12,750 shares of the business’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $90.00, for a total value of $1,147,500.00. Following the transaction, the vice president now directly owns 21,038 shares of the company’s stock, valued at approximately $1,893,420. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 1.28% of the stock is currently owned by insiders.

Several equities research analysts recently commented on the company. HC Wainwright reiterated a “positive” rating and issued a $110.00 price objective (up from $95.00) on shares of Balchem in a report on Wednesday. BidaskClub downgraded Balchem from a “buy” rating to a “hold” rating in a report on Thursday. Finally, Zacks Investment Research downgraded Balchem from a “hold” rating to a “strong sell” rating in a report on Thursday. One research analyst has rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the stock. Balchem has an average rating of “Hold” and a consensus target price of $107.67.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry.

See Also: Which market index is the best?

Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPC).

Institutional Ownership by Quarter for Balchem (NASDAQ:BCPC)

Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.